Renée Hart

Renée Hart serves as the President and Chief Business Officer of LumaCyte, bringing over 25 years of executive experience in life sciences operations and business leadership. Her broad and deep experience and diverse expertise across clinical development, commercialization strategies, bioanalytical instrumentation, and regulatory considerations for advanced biomanufacturing has touched many aspects of the biopharmaceutical and life sciences industry, providing her with a unique perspective into the needs and challenges of the market.  Renee's passion for innovation drives her to challenge the status quo, ensuring the industry is ready to meet the commercial scale and yields required to address the increasing demands for advanced therapies and vaccines. She recognizes the need to break through traditional approaches to stay ahead in the evolving biomanufacturing landscape. Her collaborative mindset and focus on solution management, coupled with her commitment to innovation and high trust partnerships, have been instrumental in accelerating the adoption of LumaCyte’s advanced bioanalytics PAT platform, leveraging Laser Force Cytology™ to reliably and consistently achieve high product quality through its real-time cellular response metrics.